These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 998518)

  • 61. Activity of (des-Aspartyl1)-angiotensin II and angiotensin II in man. Differences in blood pressure and adrenocortical response during normal and low sodium intake.
    Carey RM; Vaughan ED; Peach MJ; Ayers CR
    J Clin Invest; 1978 Jan; 61(1):20-31. PubMed ID: 338631
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Beta-adrenergic receptor blockade as a therapeutic approach for suppressing the renin-angiotensin-aldosterone system in normotensive and hypertensive subjects.
    Blumenfeld JD; Sealey JE; Mann SJ; Bragat A; Marion R; Pecker MS; Sotelo J; August P; Pickering TG; Laragh JH
    Am J Hypertens; 1999 May; 12(5):451-9. PubMed ID: 10342782
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Cardiovascular and neurohormonal changes following central sympathetic blockade with clonidine in human unilateral renal artery stenosis.
    Kooner JS; Peart S; Mathias CJ
    J Hypertens Suppl; 1988 Dec; 6(4):S544-6. PubMed ID: 3071592
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Calcium channel blockade with nitrendipine. Effects on sodium homeostasis, the renin-angiotensin system, and the sympathetic nervous system in humans.
    Luft FC; Aronoff GR; Sloan RS; Fineberg NS; Weinberger MH
    Hypertension; 1985; 7(3 Pt 1):438-42. PubMed ID: 3158605
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Excessive sodium retention as a characteristic of salt-sensitive hypertension.
    Dustan HP; Valdes G; Bravo EL; Tarazi RC
    Am J Med Sci; 1986 Aug; 292(2):67-74. PubMed ID: 3524228
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The influence of potassium administration and of potassium deprivation on plasma renin in normal and hypertensive subjects.
    Brunner HR; Baer L; Sealey JE; Ledingham JG; Laragh JH
    J Clin Invest; 1970 Nov; 49(11):2128-38. PubMed ID: 4319970
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Plasma renin activity and plasma aldosterone in essential hypertension: effect of age and diastolic blood pressure].
    Vetter H; Alasso I; Appenheimer M; Weiand H; Stelkens H; Lucas R; Glänzer K; Witassek F; Stumpe KO; Trübestein G; Krück F
    Schweiz Med Wochenschr; 1976 Dec; 106(49):1729-32. PubMed ID: 1013695
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A specific role for saline or the sodium ion in the regulation of renin and aldosterone secretion.
    Tuck ML; Dluhy RG; Williams GH
    J Clin Invest; 1974 Apr; 53(4):988-95. PubMed ID: 4360859
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Suppression of renin and aldosterone by small amounts of DOCA in normal man.
    Shade RE; Grim CE
    J Clin Endocrinol Metab; 1975 Apr; 40(4):652-8. PubMed ID: 1127075
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The antihypertensive action of methyldopa in relation to its effect on the renin-aldosterone system.
    Gavras H; Gavras I; Brunner HR; Laragh JH
    J Clin Pharmacol; 1977 Jul; 17(7):372-8. PubMed ID: 881470
    [No Abstract]   [Full Text] [Related]  

  • 71. Glucose-induced paradoxical hyperkalemia in patients with suppression of the renin-aldosterone system: prevention by sodium depletion.
    Radó JP
    J Endocrinol Invest; 1979; 2(4):401-6. PubMed ID: 395185
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Relation between arterial pressure, dietary sodium intake, and renin system in essential hypertension.
    Parfrey PS; Markandu ND; Roulston JE; Jones BE; Jones JC; MacGregor GA
    Br Med J (Clin Res Ed); 1981 Jul; 283(6284):94-7. PubMed ID: 6789950
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A vasodilator that avoids renin stimulation and fluid retention: antihypertensive treatment with trimazosin.
    Weber MA; Brewer DD; Drayer JI; Aronow WS; Lipson JL; Ricci BA
    Clin Pharmacol Ther; 1982 May; 31(5):572-8. PubMed ID: 7042174
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Renin stimulation during clonidine therapy in "low renin" essential hypertension.
    Thananopavarn C; Sambhi MP; Golub MS; Eggena P; Barrett JD
    Am J Med Sci; 1978; 276(1):27-32. PubMed ID: 727216
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Renin-angiotensin-aldosterone system in long-term renal transplant patients.
    Keogh B; Kirdani R; Sandberg AA; Mittleman A; Murphy GP
    Urology; 1976 Mar; 7(3):248-55. PubMed ID: 769285
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Characterization of a group of essential hypertensives with impaired regulation of aldosterone.
    Wambach G; Helber A; Bönner G; Konrads A; Hummerich W; Meurer KA; Kaufmann W
    Clin Exp Hypertens A; 1982; 4(9-10):1835-49. PubMed ID: 6754153
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Effects of magnesium on blood pressure and intracellular ion levels of Brazilian hypertensive patients.
    Sanjuliani AF; de Abreu Fagundes VG; Francischetti EA
    Int J Cardiol; 1996 Oct; 56(2):177-83. PubMed ID: 8894790
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Steady state aldosterone dose-response relationships.
    Young DB; Guyton AC
    Circ Res; 1977 Feb; 40(2):138-42. PubMed ID: 844139
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The pressor response to angiotensin II in patients with low renin essential hypertension.
    Marks AD; Marks DB; Kim YN; Moctezuma J; Adlin EV; Channick BJ
    Circ Res; 1978 Jun; 42(6):864-9. PubMed ID: 657448
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Abnormal relation of extracellular fluid volume and exchangeable sodium with systemic arterial pressure in early borderline essential hypertension.
    Lebel M; Grose JH; Blais R
    Am J Cardiol; 1984 Dec; 54(10):1267-71. PubMed ID: 6391132
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.